About the Authors
- Sara Alvarez
-
* E-mail: salvarez@cnio.es (SA); jccigudosa@cnio.es (JCC)
Affiliation Molecular Cytogenetics Group, Centro Nacional Investigaciones Oncologicas (CNIO), Centro de Investigaciones de Enfermedades Raras (CIBERER), Madrid, Spain
- Javier Suela
-
Affiliation Molecular Cytogenetics Group, Centro Nacional Investigaciones Oncologicas (CNIO), Centro de Investigaciones de Enfermedades Raras (CIBERER), Madrid, Spain
- Ana Valencia
-
Affiliation Hematology Service, Hospital Universitario La Fe, Valencia, Spain
- Agustín Fernández
-
Affiliation Cancer Epigenetics and Biology Program, Bellvitge Institute for Biomedical Research-Catalan Institute of Oncology (IDIBELL-ICO), Barcelona, Spain
- Mark Wunderlich
-
Affiliation Division of Experimental Hematology, Cincinnati Children's Hospital Medical Center, University of Cincinnati College of Medicine, Cincinnati, Ohio, United States of America
- Xabier Agirre
-
Affiliation Division of Cancer and Area of Cell Therapy and Hematology Service, Foundation for Applied Medical Research, Clínica Universitaria, Universidad de Navarra, Pamplona, Spain
- Felipe Prósper
-
Affiliation Division of Cancer and Area of Cell Therapy and Hematology Service, Foundation for Applied Medical Research, Clínica Universitaria, Universidad de Navarra, Pamplona, Spain
- José Ignacio Martín-Subero
-
Affiliations Cancer Epigenetics and Biology Program, Bellvitge Institute for Biomedical Research-Catalan Institute of Oncology (IDIBELL-ICO), Barcelona, Spain, Institute of Human Genetics, University Hospital Schleswig-Holstein, Campus Kiel, Christian-Albrechts University, Kiel, Germany
- Alba Maiques
-
Affiliation Molecular Cytogenetics Group, Centro Nacional Investigaciones Oncologicas (CNIO), Centro de Investigaciones de Enfermedades Raras (CIBERER), Madrid, Spain
- Francesco Acquadro
-
Affiliation Molecular Cytogenetics Group, Centro Nacional Investigaciones Oncologicas (CNIO), Centro de Investigaciones de Enfermedades Raras (CIBERER), Madrid, Spain
- Sandra Rodriguez Perales
-
Affiliation Molecular Cytogenetics Group, Centro Nacional Investigaciones Oncologicas (CNIO), Centro de Investigaciones de Enfermedades Raras (CIBERER), Madrid, Spain
- María José Calasanz
-
Affiliation Department of Genetics, University of Navarra, Pamplona, Spain
- Jose Roman-Gómez
-
Affiliation Hematology Service, Hospital Universitario Reina Sofia, Córdoba, Spain
- Reiner Siebert
-
Affiliation Institute of Human Genetics, University Hospital Schleswig-Holstein, Campus Kiel, Christian-Albrechts University, Kiel, Germany
- James C. Mulloy
-
Affiliation Division of Experimental Hematology, Cincinnati Children's Hospital Medical Center, University of Cincinnati College of Medicine, Cincinnati, Ohio, United States of America
- José Cervera
-
Affiliation Hematology Service, Hospital Universitario La Fe, Valencia, Spain
- Miguel Angel Sanz
-
Affiliation Hematology Service, Hospital Universitario La Fe, Valencia, Spain
- Manel Esteller
-
Affiliation Cancer Epigenetics and Biology Program, Bellvitge Institute for Biomedical Research-Catalan Institute of Oncology (IDIBELL-ICO), Barcelona, Spain
- Juan C. Cigudosa
-
* E-mail: salvarez@cnio.es (SA); jccigudosa@cnio.es (JCC)
Affiliation Molecular Cytogenetics Group, Centro Nacional Investigaciones Oncologicas (CNIO), Centro de Investigaciones de Enfermedades Raras (CIBERER), Madrid, Spain
Competing Interests
The authors have declared that no competing interests exist.
Author Contributions
Conceived and designed the experiments: SA JCC. Performed the experiments: JS AV AF MW XA JIMS AM JRG. Analyzed the data: SA JS AV AF XA JIMS AM FA SRP MJC JCM JVC JCC. Contributed reagents/materials/analysis tools: AV AF MW XA FP MJC JRG RS JCM JVC MAS ME. Wrote the paper: SA ME JCC.